Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.

Researchers have found in a new cohort study that the use of statins in patients with chronic liver disease was associated ...

HealthDay News — Five proteins are significant predictors of metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study presented at the 2025 Digestive Disease Week, held ...

High cannabis use prior to a colorectal cancer (CRC) diagnosis was associated with an increased risk of CRC mortality in an ...

India needs to prioritize liver health in its public health strategy: Chander Shekhar Sibal: Nandita Vijayasimha, Bengaluru Saturday, April 26, 2025, 08:00 Hrs [IST] India must pr ...

Five plasma proteins may predict a patient’s risk for metabolic dysfunction-associated steatotic liver disease up to 16 years ...

Five proteins are significant predictors of metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study presented at the 2025 Digestive Disease Week, held from May 3 to 6 in ...

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is set to showcase critical new findings on resmetirom, its ...

Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing efimosfermin alfa, a once-monthly FGF21 analogue for the treatment of metabolic dysfunction-associated steatohepatitis ...

In this article, we will review the epidemiology of HCV and NAFLD, their impact on each other, and the course of the liver disease in individuals afflicted with both conditions.